Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2015 (2015), Article ID 613089, 6 pages
http://dx.doi.org/10.1155/2015/613089
Research Article

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent

1Lalitha Super Specialty Hospital Pvt. Ltd., Heart and Brain Centre, Kothapet, Guntur, Andhra Pradesh 522001, India
2Apollo Hospitals, Ahmedabad, Gujarat 382428, India
3Lions Sterling Super Specialty Hospital, Mehsana, Gujarat 384002, India
4Yashfeen Cardiac Hospital, Navsari, Gujarat 396445, India
5Department of Clinical Trials, Sahajanand Medical Technologies Pvt. Ltd., Surat, Gujarat 395004, India

Received 29 June 2015; Revised 3 October 2015; Accepted 8 October 2015

Academic Editor: Costantino Del Gaudio

Copyright © 2015 Anurag Polavarapu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. W. Serruys, P. De Jaegere, F. Kiemeneij et al., “A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease,” The New England Journal of Medicine, vol. 331, no. 8, pp. 489–495, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Schofer, M. Schlüter, A. H. Gershlick et al., “Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS),” The Lancet, vol. 362, no. 9390, pp. 1093–1099, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr., “Coronary artery stents,” The Journal of the American Medical Association, vol. 284, no. 14, pp. 1828–1836, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Serruys, B. van Hout, H. Bonnier et al., “Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II),” The Lancet, vol. 352, no. 9129, pp. 673–681, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Laham, J. P. Carrozza, C. Berger, D. J. Cohen, R. E. Kuntz, and D. S. Baim, “Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems,” Journal of the American College of Cardiology, vol. 28, no. 4, pp. 820–826, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Bauters, E. Hubert, A. Prat et al., “Predictors of restenosis after coronary stent implantation,” Journal of the American College of Cardiology, vol. 31, no. 6, pp. 1291–1298, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Xu, R. L. Gao, R. Y. Zhang et al., “Efficacy and safety of FIREHAWK abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort,” Chinese Medical Journal, vol. 126, no. 6, pp. 1026–1032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Ahn, D. W. Park, Y. H. Kim et al., “Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions a randomized LONG-DES IV trial,” Circulation: Cardiovascular Interventions, vol. 5, no. 5, pp. 633–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Kobayashi, J. De Gregorio, N. Kobayashi et al., “Stented segment length as an independent predictor of restenosis,” Journal of the American College of Cardiology, vol. 34, no. 3, pp. 651–659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Degertekin, C. A. Arampatzis, P. A. Lemos et al., “Very long sirolimus-eluting stent implantation for de novo coronary lesions,” The American Journal of Cardiology, vol. 93, no. 7, pp. 826–829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kastrati, A. Dibra, J. Mehilli et al., “Predictive factors of restenosis after coronary implantation of sirolimus-or paclitaxel-eluting stents,” Circulation, vol. 113, no. 19, pp. 2293–2300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Suh, D. W. Park, J. Y. Lee et al., “The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation,” JACC: Cardiovascular Interventions, vol. 3, no. 4, pp. 383–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. E. Cutlip, S. Windecker, R. Mehran et al., “Clinical end points in coronary stent trials: a case for standardized definitions,” Circulation, vol. 115, no. 17, pp. 2344–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Grouve and S. Kristensen, “Stent thrombosis: definitions, mechanisms and prevention,” E-Journal of Cardiology Practice, vol. 32, no. 5, 2007. View at Google Scholar
  15. G. Guagliumi, H. Ikejima, V. Sirbu et al., “Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (optical coherence tomography in long lesions),” JACC: Cardiovascular Interventions, vol. 4, no. 7, pp. 778–785, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. W. Lee, D. W. Park, B. K. Lee et al., “Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries,” The American Journal of Cardiology, vol. 97, no. 4, pp. 506–511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kastrati, S. Elezi, J. Dirschinger, M. Hadamitzky, F.-J. Neumann, and A. Schömig, “Influence of lesion length on restenosis after coronary stent placement,” American Journal of Cardiology, vol. 83, no. 12, pp. 1617–1622, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Rajasekhar, V. Vanajakshamma, C. Shashank, M. Srinivasakumar, and C. Sivasankara, “The real world experience of the biodegradable polymer-coated sirolimus-eluting coronary stent system: results from an ‘all-comers’ clinical experience,” Catheterization and Cardiovascular Interventions, 2014. View at Publisher · View at Google Scholar
  19. D. Rajasekhar, V. Vanajakshamma, S. Babu, C. Sivasankara, B. M. Khambhati, and A. S. Thakkar, “Safety and efficacy of sirolimus-eluting stent in diabetic patients compared with non-diabetic patients undergoing percutaneous coronary intervention,” Journal of Cardiology and Therapeutics, vol. 2, no. 1, pp. 21–26, 2014. View at Publisher · View at Google Scholar
  20. D. Rajasekhar, V. Vanajakshamma, A. Vidyasagar et al., “Evaluation of prolonged safety and efficacy of biodegradable polymer coated sirolimus-eluting coronary stent system: 1-year outcomes of the INDOLIMUS registry,” Cardiovascular Diagnosis and Therapy, vol. 5, no. 4, pp. 249–253, 2015. View at Publisher · View at Google Scholar
  21. A. Polavarapu, R. S. Polavarapu, J. Prajapati et al., “Favorable outcomes after implantation of biodegradable polymer coated sirolimus-eluting stents in diabetic population: results from INDOLIMUS-G diabetic registry,” International Journal of Vascular Medicine, vol. 2015, Article ID 265670, 5 pages, 2015. View at Publisher · View at Google Scholar
  22. D. Rajasekhar, V. Vanajakshamma, S. Babu, C. Sivasankara, and A. Thakkar, “Clinical outcomes from unselected real-world patients with acute myocardial infarction receiving biodegradable polymer coated sirolimus-eluting stents,” Journal of Cardiology and Therapeutics, vol. 1, no. 2, pp. 64–70, 2013. View at Publisher · View at Google Scholar
  23. M. Costa, D. Kereiakes, R. Smith et al., “TCT-608 two-year outcomes after implantation of XIENCE PRIME and XIENCE PRIME long lesion stents in patients with coronary artery disease: results of the SPIRIT PRIME multicenter pivotal clinical trial,” Journal of the American College of Cardiology, vol. 60, no. 17, pp. B176–B177, 2012. View at Publisher · View at Google Scholar
  24. B. Xu, Y. Yang, Y. Han et al., “TCT-607 clinical outcome in Chinese patients with long lesion or small vessel/multivessel disease receiving XIENCE V everolimus-eluting stent: early results from the SEEDS study,” Journal of the American College of Cardiology, vol. 60, supplement, no. 17, p. B176, 2012. View at Publisher · View at Google Scholar
  25. D. W. Park, Y. H. Kim, H. G. Song et al., “Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (percutaneous treatment of LONG native coronary lesions with drug-eluting stent-III) trial,” JACC: Cardiovascular Interventions, vol. 4, no. 10, pp. 1096–1103, 2011. View at Publisher · View at Google Scholar